Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbert Discovery Fund is a U.S.-based equity hedge fund and activist investment vehicle managed by Harbert Management. The fund invests in public equities and has been publicly visible through activist positions, including campaigns involving healthcare company Enzo Biochem. Available sources describe it as an open fund domiciled in the United States and managed from Birmingham, Alabama. It is an investment fund rather than an operating biotechnology, pharmaceutical, or healthcare company, and it does not appear to develop therapeutic products or run a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbert Discovery Fund.